Search Results 11-20 of 16571 for B cell lymphomas

  1. Hodgkin lymphoma (Hodgkin disease) - Symptoms and causes - Mayo Clinic

    Learn how this cancer differs from other lymphomas. Find out about risk ... Cutaneous B-cell lymphoma · Cutaneous T-cell lymphoma · Lymphoma. Symptoms.

  2. Non-Hodgkin's Lymphoma Clinical Trials - Mayo Clinic Research

    It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed in many patients with mantle cell lymphoma. Venetoclax ...

  3. Everolimus R-CHOP Combination Safe for Treating Diffuse Large B-Cell Lymphoma - Mayo Clinic News Network

    — The targeted therapy everolimus may be safely combined with R-CHOP for new, untreated diffuse large B-cell lymphoma according to the results of a pilot study ...

  4. Lymphoma Clinical Trials

    It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed in many patients with follicular lymphoma. Venetoclax ...

  5. Lymphoma Patients Event-Free Two Years after Diagnosis have a Normal Life Expectancy

    — Feb. 18, 2014 — Newly-diagnosed patients with diffuse large B cell lymphoma (DLBCL) who do not experience any cancer-related outcome events for two years ...

  6. Anne J. Novak, Ph.D. - Mayo Clinic Faculty Profiles

    B-cell lymphomas are a heterogeneous group of neoplasms that arise from lymphocytes and produce tumors in the lymph nodes, lymphatic organs and extranodal ...

  7. Hodgkin's Lymphoma Clinical Trials

    It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed in many patients with mantle cell lymphoma. Venetoclax ...

  8. DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Relapse in Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

    DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Relapse in Aggressive B-cell Non-Hodgkin Lymphomas · Overview · Participation eligibility.

  9. Phase 2 Study with TTI-622 and TTI-621 in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) - Mayo Clinic

    T-cell/histiocyte-rich large B cell lymphoma. Large B-cell lymphoma with ... FDG-nonavid lymphomas: Measurable disease with CT (or MRI) scan with ...

  10. Axi-cel treatment for B-cell lymphoma provides real-world outcomes comparable to ZUMA-1 trial data - Mayo Clinic

    In a study of axicabtagene ciloleucel (axi-cel) CAR-T cell therapy for relapsed or refractory aggressive B-cell lymphoma, 30-day responses were comparable ...